Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 20- 52-wk high
- $7.18
- 52-wk low
- $2.77
- Prev close
- $5.36
- Mkt cap
- $1.88B
- Beta
- 1.05
- P/S
- 34.2x
Smart money
Earnings
Earnings came in 8.7% below what analysts expected.
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $5.2M | $35.5M | $6.5M | $7.7M |
| Cost of what it sold | $29.6M | $26.9M | $12.5M | $11.5M |
| Gross profit | -$24.4M | $8.7M | -$6.0M | -$3.8M |
| What it spent | ||||
| Research and development | $121.1M | $83.3M | $87.9M | $89.6M |
| Sales and admin | $41.6M | $33.7M | $34.6M | $41.5M |
| Other operating costs | -$14.9M | — | — | — |
| Total operating expenses | $147.8M | $117.0M | $122.5M | $131.1M |
| What was left | ||||
| Operating profit | -$172.2M | -$108.3M | -$128.5M | -$135.0M |
| Interest on debt | $833.0K | $11.0K | $350.0K | $309.0K |
| Profit before tax | -$162.3M | -$108.1M | -$122.1M | -$131.0M |
| Tax | $3.0K | $20.0K | -$4.6M | -$1.0K |
| Net profit | -$162.3M | -$108.1M | -$117.5M | -$131.0M |
| EBITDA | -$141.2M | -$88.6M | -$102.1M | -$112.5M |
Technicals
Price structure
Technicals sync when verified market data is available. No sample data is shown.
News
What the news says
Coverage is bearish
Tone of tracked coverage
Recursion (NASDAQ: RXRX) CFO has 25,018 shares withheld for taxes
NeutralAug 18Recursion (NASDAQ: RXRX) CEO's 80K shares withheld for RSU taxes
NeutralAug 18Recursion (NASDAQ: RXRX) CSO sees 26K shares withheld for taxes
NeutralAug 18